A new Scientific Statement released today by the Endocrine Society highlights potential research directions related to the pathogenesis of type 1 diabetes (T1D) that should help with the development ...

Stéphane Berneau does not work for, consult, own shares in or receive funding from any company or organization that would benefit from this article, and has disclosed no relevant affiliations beyond ...

Most patients with new-onset type 1 diabetes have substantial intact beta-cell reserve. 1 Thus, we analyzed the efficacy of semaglutide, an agonist of glucagon-like peptide 1 (GLP-1), in patients with ...

BUFFALO, N.Y.— Treating newly diagnosed Type 1 diabetes patients with semaglutide (trade names Ozempic, Wegovy and Rybelsus) may drastically reduce or even eliminate their need for injected insulin.

iControlled for family-wise type 1 error rate. iiPercentage of participants achieving body weight reductions of ≥20% with orforglipron 6 mg was not controlled for ...

Certain foods might make your child more likely to develop type 1 diabetes, researchers have found. Eating a diet that is high in oats, rye, and some fruits is linked with an increased risk of ...

Tirzepatide produced significant weight loss, reduced insulin requirements, and improved glucose control without increasing hypoglycemia when used off-label in adults with type 1 diabetes (T1D), new ...

Precision medicine, the application of novel systemic therapies on the basis of biomarkers, has been remarkably successful in advancing cancer treatment. With such progress, a new problem arises, ...

For the primary endpoint, orforglipron lowered A1C by 2.2% vs. 1.4% with oral semaglutide at the highest doses Participants taking the highest dose of orforglipron lost an average of 19.7 lbs (9.2%) ...